Nuclear receptors in renal health and disease
Open Access
- 3 February 2022
- journal article
- review article
- Published by Elsevier in EBioMedicine
- Vol. 76, 103855
Abstract
No abstract availableKeywords
This publication has 137 references indexed in Scilit:
- The mineralocorticoid receptor antagonist eplerenone reduces renal interstitial fibrosis after long-term cyclosporine treatment in rat: antagonizing cyclosporine nephrotoxicityBMC Nephrology, 2013
- Central diabetes insipidus associated with impaired renal aquaporin-1 expression in mice lacking liver X receptor βProceedings of the National Academy of Sciences, 2012
- Liver X receptor-activating ligands modulate renal and intestinal sodium–phosphate transportersKidney International, 2011
- PPARgamma activators stimulate aquaporin 3 expression in keratinocytes/epidermisExperimental Dermatology, 2011
- Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolismAmerican Journal of Physiology-Renal Physiology, 2011
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialThe Lancet, 2010
- Dose- and time-dependent glucocorticoid receptor signaling in podocytesAmerican Journal of Physiology-Renal Physiology, 2010
- Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increaseProceedings of the National Academy of Sciences of the United States of America, 2008
- Pancreatic exocrine insufficiency in LXRβ −/− mice is associated with a reduction in aquaporin-1 expressionProceedings of the National Academy of Sciences, 2008
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994